Satish Kumar Devarapu: Returning from ISTH 2026 with New Perspectives
Satish Kumar Devarapu, Chief Scientific Officer at PreviPharma, shared a post on LinkedIn:
”ISTH 2026 Paris.
Some conferences leave you with new knowledge. Others leave you with new perspectives. ISTH 2026 in Paris gave me both.
Over the past week, I had the privilege of learning from outstanding scientific presentations, engaging in inspiring discussions, and reconnecting with colleagues while meeting many new peers and experts from around the world. These conversations reminded me that scientific progress is built not only through research, but also through collaboration and the willingness to learn from one another.
One moment that particularly stayed with me was seeing young mothers attending the congress with their infants. The thoughtful accommodations provided by the organizers created an environment where parenthood and professional development could coexist. It was a powerful reminder that an inclusive scientific community is one where everyone has the opportunity to contribute and thrive.
Paris is known worldwide for the Eiffel Tower, but for me this visit was equally about celebrating the city’s remarkable scientific heritage. Visiting the resting place of Marie Curie to pay my respects and touring the Pasteur Institute were deeply meaningful experiences. Standing in places where pioneers transformed medicine and science was both humbling and inspiring, reinforcing why our work today matters for the generations to come.
I return home with fresh scientific insights, renewed motivation, and new collaborations that I hope will translate into better research and better patient care.
My sincere thanks to the ISTH 2026 organizers for delivering an exceptional congress and for fostering a welcoming, inclusive, and inspiring environment for the global scientific community.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?